REGENERON Trademark

Trademark Overview

On Friday, November 9, 2012, a trademark application was filed for REGENERON with the United States Patent and Trademark Office. The USPTO has given the REGENERON trademark a serial number of 85775911. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, March 3, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
regeneron

General Information

Serial Number85775911
Word MarkREGENERON
Filing DateFriday, November 9, 2012
Status800 - REGISTERED AND RENEWED
Status DateSunday, March 3, 2024
Registration Number4402744
Registration DateTuesday, September 17, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2013

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 21, 2012
Primary Code005
First Use Anywhere DateMonday, August 20, 2012
First Use In Commerce DateMonday, August 20, 2012

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrrytown, NY 10591

Trademark Events

Event DateEvent Description
Wednesday, March 6, 2013ASSIGNED TO EXAMINER
Tuesday, November 13, 2012NEW APPLICATION ENTERED
Wednesday, November 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 9, 2013NON-FINAL ACTION WRITTEN
Saturday, March 9, 2013NON-FINAL ACTION E-MAILED
Saturday, March 9, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 1, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2013ASSIGNED TO LIE
Tuesday, May 28, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 12, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2013PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 17, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 14, 2019TEAS SECTION 8 RECEIVED
Thursday, August 22, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 22, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, August 22, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 17, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 12, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, March 2, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, March 3, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, March 3, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, March 3, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, August 2, 2024TEAS SECTION 15 RECEIVED

Related Keywords

regeneron cancer treatment products pharmaceutical